Elena Rossi

20PUBLICATIONS
84CO-AUTHORS
Medical infection agents (incl. prions)Medical mycologyPredictive and prognostic markersMedical virologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Apr 08, 2026
An Uncommon Presentation of Sweet's Syndrome in Primary Myelofibrosis.

Valentina Rago, Valeria Brogna, Fabrizio Cavalca

|Feb 21, 2026
Overall survival with momelotinib vs. best available therapy in patients with ruxolitinib-experienced myelofibrosis: a matching-adjusted indirect comparison.

Francesca Palandri, Venediktos Kapetanakis, Balázs Dobi

|Aug 21, 2025
Revised "iRR6" model in intermediate-1 risk myelofibrosis patients treated with ruxolitinib.

Francesca Palandri, Filippo Branzanti, Massimiliano Bonifacio

|Mar 20, 2025
Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real-world setting: Interim results of the Italian observational study (ROMEI).

Massimo Breccia, Francesca Palandri, Maurizio Martelli

|Jul 30, 2024
Clinical outcomes of ruxolitinib treatment in 595 intermediate-1 risk patients with myelofibrosis: The RUX-MF Real-World Study.

Francesca Palandri, Elena M Elli, Erika Morsia

|Jun 15, 2024
Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial.

Bianca Rocca, Alberto Tosetto, Giovanna Petrucci

Pageof 4

Frequent Collaborators

10 joint publications

Alessandra Iurlo

10 joint publications

Massimo Breccia

10 joint publications

Massimiliano Bonifacio

10 joint publications

Francesca Palandri